CCDC98 targets BRCA1 to DNA damage sites.
Zixing Liu1, Jiaxue Wu, Xiaochun Yu
1Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan Medical School, 109 Zina Pitcher Place, BSRB 1520, Ann Arbor, Michigan 48109, USA.
Nature Structural & Molecular Biology
|July 24, 2007
Summary
CCDC98 is a newly identified BRCA1 binding partner. It is crucial for recruiting BRCA1 to DNA damage sites and activating cell cycle checkpoints, thus mediating BRCA1
Area of Science:
- Molecular biology
- Cellular biology
- Cancer research
Background:
- The protein Breast cancer-1 (BRCA1) plays a vital role in DNA damage response.
- The precise mechanism of BRCA1 recruitment to DNA damage sites is not fully understood.
- RAP80, a ubiquitin-binding protein, has been identified as essential for BRCA1 translocation following DNA damage.
Purpose of the Study:
- To identify novel components of the BRCA1-RAP80 complex.
- To elucidate the role of CCDC98 in BRCA1-mediated DNA damage response.
- To investigate CCDC98's function in BRCA1 translocation and checkpoint activation.
Main Methods:
- Co-immunoprecipitation assays to identify protein interactions.
- Immunofluorescence microscopy to visualize BRCA1 foci formation.
- Cell cycle analysis to assess G2/M checkpoint activation.
Main Results:
- CCDC98 was identified as a novel binding partner within the BRCA1-RAP80 complex.
- CCDC98 directly mediates the association between BRCA1 and RAP80.
- CCDC98 is essential for the formation of BRCA1 foci at DNA damage sites.
- CCDC98 controls BRCA1-dependent activation of the G2/M cell cycle checkpoint.
Conclusions:
- CCDC98 is a critical component that bridges BRCA1 and RAP80.
- CCDC98 plays a significant role in the DNA damage response pathway by regulating BRCA1 function.
- CCDC98 is a key mediator of BRCA1's role in maintaining genomic stability.
Related Concept Videos
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:54Base Excision Repair
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
02:04Fixing Double-strand Breaks
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:38Nucleotide Excision Repair
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...